Duloxetine for the Treatment of Postpartum Depression
Conditions
Major Depressive Disorder | Postpartum Depression
What is the purpose of this trial?
The purpose of this study is to assess whether the antidepressant, duloxetine, is equally effective as a treatment for subjects who have a Postpartum Onset Depression compared to subjects who have an onset of Major Depressive Disorder prior to delivery. The hypothesis is that duloxetine will be as effective in subjects with Postpartum Major Depressive Disorder as in subjects with a Major Depressive Disorder.
Participation Guidelines
- Age:
- 18 Years and older
- Gender:
- Female
Click here for detailed information about who can participate in this trial.
- Sponsor:
- Yale University
- Dates:
- July 2007
- Last Updated:
- May 21, 2013
- Study HIC#:
- 0609001827
Clinicaltrials.gov ID: NCT00617045


